To amend titles XVIII and XIX of the Social Security Act to provide for coverage of prescription digital therapeutics under such titles, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill provides coverage and payment of prescription digital therapeutics under the Medicare program Section 1861 of the Social Security Act (42 U.S.C, provides requirements for prescription digital therapeutics, and defines coverage of prescription digital therapeutics under the Medicaid program Section 1905(a) of the Social Security Act (42 U.S.C. It relies on definition changes, appropriations, reporting requirements, and compliance mandates. The main policy areas are Healthcare Consumers, Healthcare, and Science & Space.
Who Benefits and How
Patients and health care consumers affected by the bill could face reduced risk, Researchers and scientific institutions affected by the bill could face lower compliance burdens, and Regulated entities and members of the public affected by the bill could gain revenue opportunities.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Public beneficiaries or protected communities affected by the clause could face increased risk.
Key Provisions
- Provides coverage and payment of prescription digital therapeutics under the Medicare program Section 1861 of the Social Security Act (42 U.S.C.
- Provides requirements for prescription digital therapeutics.
- Defines coverage of prescription digital therapeutics under the Medicaid program Section 1905(a) of the Social Security Act (42 U.S.C.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill provides coverage and payment of prescription digital therapeutics under the Medicare program Section 1861 of the Social Security Act (42 U.S.C, provides requirements for prescription digital therapeutics, and defines coverage of prescription digital therapeutics under the Medicaid program Section 1905(a) of the Social Security Act (42 U.S.C.
Key Policy Areas
Healthcare Consumers, Healthcare, Science & Space
Primary Purpose
The bill provides coverage and payment of prescription digital therapeutics under the Medicare program Section 1861 of the Social Security Act (42 U.S.C, provides requirements for prescription digital therapeutics, and defines coverage of prescription digital therapeutics under the Medicaid program Section 1905(a) of the Social Security Act (42 U.S.C.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Researchers and scientific institutions affected by the bill
- Regulated entities and members of the public affected by the bill
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Public beneficiaries or protected communities affected by the clause
Sponsors
Legislative Progress
IntroducedMr. Hern (for himself, Mr. Thompson of California, Mr. Johnson …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology